ARVO Annual Meeting

ARVO 2017

May 6-11, 2017 | Baltimore MD

Harvard Ophthalmology takes pride in actively participating in the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting every year. Considered the largest gathering of eye and vision researchers in the world, the meeting attracts more than 11,000 attendees from more than 75 countries. About 45 percent of attendees are from outside the United States. With a central focus on “Global Connections in Vision Research,” this year’s meeting will address the challenges of bridging gaps in scientific knowledge and building effective collaborations.

Harvard Ophthalmology at ARVO

Harvard Ophthalmology stats for ARVOThis year, more than 230 Harvard Ophthalmology faculty and trainees will participate in this year’s annual meeting as course instructors, panelists, lecturers, and more. In addition, 18 faculty and trainees will present 11 papers and posters at the ARVO Imaging in the Eye Conference on May 6.

Key Dates

  • April 21: RSVP* for the Harvard Ophthalmology/Mass. Eye and Ear Alumni Association Reception at ARVO
    *If you have not received an email invitation, let us know and we will send you one. 
  • April 28: ARVO cancellation and refund deadline
  • May 7: Alumni Reception

Learn more about ARVO 2017

    Harvard Ophthalmology and Mass. Eye and Ear Alumni Association Alumni Reception

    Sunday, May 7, 2017  -  7:30-10:00 pm
    Cocktail reception with hors d'oeuvres
    The Grand, Baltimore
    RSVP by April 21

    *If you have not received an email invitation, let us know and we will send you one. 

    225 N Charles Street
    Baltimore, MD 21201

    Eric PierceNew tools and methodologies for ocular genetics: Promises and challenges

    Cross-Sectional Group Session
    May 7; 1:30-3:00pm

    Eric Pierce, MD, PhD

    Over the years, genomic research has relied on several technologies to uncover the genetic basis, functional aspects, and genomic mysteries associated with many of the complex and Mendelian ocular diseases.

    Using examples of different ocular diseases, this session will detail some of the successes and challenges associated with some of the contemporary “omic” methods (e.g., whole genome sequencing and RNA sequencing) and bioinformatics/computational tools.

    The session will also cover systems biology approaches for integrating multiple data sets to elucidate gene regulatory or disease networks.

    Janey Wiggs, MD, PhDAddressing global blindness and eye diseases through research collaborations

    May 7, 1:30-3:00pm

    Janey Wiggs, MD, PhD

    As much as 90 Percent of the global burden of eye disease is shouldered by developing countries, where many treatable diseases often go undiagnosed. Eighty percent of blindness is considered preventable; however a comprehensive research strategy and international reserach collaborations between the developed and developing world need to increase. Many areas of the world require a coordinated strategy for basic science and health services research in order to reduce the global burden of eye diseases.

    This ARVO session will stimulate discussion and address current challenges, strategies, and collaborative studies related to eye diseases.

    Mildred Weisenfeld Award for Excellence in Ophthalmology

    May 7, 645-7:30pm

    Alumna Johanna Seddon, MD, will discuss macular degeneration epidemiology and risk factors. Dr. Seddon completed her Ophthalmic Pathology and Vitreoretinal fellowships at Harvard Ophthalmology/Mass. Eye and Ear. Currently, she is Professor and Founding Director of the Ophthalmic Epidemiology and Genetics Service at Tufts University and a former trustee and vice-president of ARVO.

    Michael GilmoreThe global problem of antibiotic resistance: Impact on ocular health worldwide and researching alternatives

    May 11, 8:30-10:30am

    Michael Gilmore, PhD

    Antibiotic resistance has been steadily rising worldwide, despite newer classes of antibiotics being developed. This problem impacts those with any predisposing condition or those undergoing ocular surgery. 

    This symposium will discuss the current epidemiological trends in resistance worldwide and highlight novel and alternative research strategies that aim to circumvent the problem of antibiotic resistance.

    This symposium is designed for clinicians and basic scientists who are interested in ocular surface and intraocular infections, systemic conditions (e.g., diabetes and immunodeficiencies that predispose patients to ocular infection), and complications arising from ocular surgery.

    Janine ClaytonWomen in Eye and Vision Research Luncheon

    May 9, 1:00-2:30pm
    Hilton Baltimore

    Network with more than 300 ARVO attendees over lunch. Prominent scientists from around the world are invited as guest speakers to share their experiences. Janine Austin Clayton, MD, Director of the Office of Research on Women’s Health at the National Institutes of Health, will deliver the keynote presentation. While the luncheon program supports women in eye and vision research, both male and female attendees are welcome. Register online 

    2017 ARVO Foundation/Pfizer Ophthalmics
    Carl Camras Translational Research Award

    Ula Jurkunas, MD

    ARVO Gold Fellows, Class of 2017
    Jayakrishna Ambati, MD (alumnus)
    Pedram Hamrah, MD (former faculty)
    Louis Pasquale, MD
    Scheffer Tseng, MD, PhD (alumnus)

    ARVO Silver Fellows, Class of 2017
    Norman Blair, MD (alumnus)
    Samuel Jacobson, MD, PhD (alumnus)
    Michael Young, PhD

    New 2017 Dowling Society Members
    Joan W. Miller, MD